A Randomized, Double Blind, Placebo Controlled, Parallel Group Design Study to Explore the Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Sotrastaurin (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Novartis
- 22 Sep 2016 Status changed from discontinued to completed.
- 07 May 2012 Actual patient number 59 added as reported by ClinicalTrials.gov.
- 07 May 2012 Planned end date changed from 1 Oct 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.